Christopher B. Ford, Ph.D. - Publications

Affiliations: 
2012 Biological Sciences in Public Health Harvard University, Cambridge, MA, United States 
Area:
Microbiology Biology, Evolution and Development Biology, Public Health, Pharmacy

15/54 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Muñoz JF, Delorey T, Ford CB, Li BY, Thompson DA, Rao RP, Cuomo CA. Coordinated host-pathogen transcriptional dynamics revealed using sorted subpopulations and single macrophages infected with Candida albicans. Nature Communications. 10: 1607. PMID 30962448 DOI: 10.1038/S41467-019-09599-8  0.304
2019 Ford C, Litcofsky K, McGovern B, Pardi D, Nathan R, Hansen V, Brennan R, Pullman J, Bernardo P, Tomlinson A, Horgan K, Bryant J, Walsh E, Rodriguez M, Rogalin H, et al. 1503. Engraftment of Investigational Microbiome Drug, SER-262, in Subjects Receiving Vancomycin Is Associated with Reduced Rates of Recurrence after Primary Clostridium Difficile Infection (CDI) Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.1367  0.319
2018 Ford C, Henn M, Bryant J, Diao L, Wortman J, Tomlinson A, Litcofsky K, Bernardo P, McGovern B, Aunins JG, Cook DN, Trucksis M. 1641. Treatment of Recurrent Clostridium difficile Infection With SER-109 Reduces Gastrointestinal Carriage of Antimicrobial Resistance Genes Open Forum Infectious Diseases. 5. DOI: 10.1093/Ofid/Ofy209.111  0.343
2016 Lahiri N, Shah RR, Layre E, Young D, Ford C, Murray MB, Fortune SM, Moody DB. Rifampin Resistance Mutations are Associated with Broad Chemical Remodeling of Mycobacterium tuberculosis. The Journal of Biological Chemistry. PMID 27226566 DOI: 10.1074/Jbc.M116.716704  0.598
2015 Rock JM, Lang UF, Chase MR, Ford CB, Gerrick ER, Gawande R, Coscolla M, Gagneux S, Fortune SM, Lamers MH. DNA replication fidelity in Mycobacterium tuberculosis is mediated by an ancestral prokaryotic proofreader. Nature Genetics. 47: 677-81. PMID 25894501 DOI: 10.1038/Ng.3269  0.581
2015 Ford CB, Funt JM, Abbey D, Issi L, Guiducci C, Martinez DA, Delorey T, Li BY, White TC, Cuomo C, Rao RP, Berman J, Thompson DA, Regev A. The evolution of drug resistance in clinical isolates of Candida albicans. Elife. 4: e00662. PMID 25646566 DOI: 10.7554/Elife.00662  0.402
2015 Cilfone NA, Ford CB, Marino S, Mattila JT, Gideon HP, Flynn JL, Kirschner DE, Linderman JJ. Computational modeling predicts IL-10 control of lesion sterilization by balancing early host immunity-mediated antimicrobial responses with caseation during mycobacterium tuberculosis infection. Journal of Immunology (Baltimore, Md. : 1950). 194: 664-77. PMID 25512604 DOI: 10.4049/Jimmunol.1400734  0.326
2015 Rock JM, Lang UF, Chase MR, Ford CB, Gerrick ER, Gawande R, Coscolla M, Gagneux S, Fortune SM, Lamers MH. DNA replication fidelity in Mycobacterium tuberculosis is mediated by an ancestral prokaryotic proofreader Nature Genetics. 47: 677-681. DOI: 10.1038/ng.3269  0.539
2014 Lin PL, Ford CB, Coleman MT, Myers AJ, Gawande R, Ioerger T, Sacchettini J, Fortune SM, Flynn JL. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nature Medicine. 20: 75-9. PMID 24336248 DOI: 10.1038/Nm.3412  0.573
2014 Ford CB, Funt JM, Abbey D, Issi L, Guiducci C, Martinez DA, Delorey T, Li By, White TC, Cuomo C, Rao RP, Berman J, Thompson DA, Regev A. Author response: The evolution of drug resistance in clinical isolates of Candida albicans Elife. DOI: 10.7554/Elife.00662.023  0.332
2013 Ford CB, Shah RR, Maeda MK, Gagneux S, Murray MB, Cohen T, Johnston JC, Gardy J, Lipsitch M, Fortune SM. Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nature Genetics. 45: 784-90. PMID 23749189 DOI: 10.1038/Ng.2656  0.635
2013 Liong M, Hoang AN, Chung J, Gural N, Ford CB, Min C, Shah RR, Ahmad R, Fernandez-Suarez M, Fortune SM, Toner M, Lee H, Weissleder R. Magnetic barcode assay for genetic detection of pathogens. Nature Communications. 4: 1752. PMID 23612293 DOI: 10.1038/Ncomms2745  0.575
2013 Ragheb MN, Ford CB, Chase MR, Lin PL, Flynn JL, Fortune SM. The mutation rate of mycobacterial repetitive unit loci in strains of M. tuberculosis from cynomolgus macaque infection. Bmc Genomics. 14: 145. PMID 23496945 DOI: 10.1186/1471-2164-14-145  0.612
2012 Ford C, Yusim K, Ioerger T, Feng S, Chase M, Greene M, Korber B, Fortune S. Mycobacterium tuberculosis - Heterogeneity revealed through whole genome sequencing Tuberculosis. 92: 194-201. PMID 22218163 DOI: 10.1016/J.Tube.2011.11.003  0.561
2011 Ford CB, Lin PL, Chase MR, Shah RR, Iartchouk O, Galagan J, Mohaideen N, Ioerger TR, Sacchettini JC, Lipsitch M, Flynn JL, Fortune SM. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nature Genetics. 43: 482-6. PMID 21516081 DOI: 10.1038/Ng.811  0.619
Low-probability matches (unlikely to be authored by this person)
2020 McGovern BH, Ford CB, Henn MR, Pardi DS, Khanna S, Hohmann EL, O'Brien EJ, Desjardins CA, Bernardo P, Wortman JR, Lombardo MJ, Litcofsky KD, Winkler JA, McChalicher CWJ, Li SS, et al. SER-109, an Investigational Microbiome Drug to Reduce Recurrence after Clostridioides difficile infection: Lessons Learned from a Phase 2 Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32255488 DOI: 10.1093/Cid/Ciaa387  0.289
2008 Goodwin AC, Weinberger DM, Ford CB, Nelson JC, Snider JD, Hall JD, Paules CI, Peek RM, Forsyth MH. Expression of the Helicobacter pylori adhesin SabA is controlled via phase variation and the ArsRS signal transduction system. Microbiology (Reading, England). 154: 2231-40. PMID 18667556 DOI: 10.1099/Mic.0.2007/016055-0  0.281
2017 Henn M, Ford C, O’Brien E, Wortman J, Simmons S, Diao L, Litcofsky K, Bernardo P, Aunins J, Cook D, Trucksis M. Gastrointestinal Tract Microbiome Dynamics Following Treatment with SER-109, an Investigational Oral Microbiome Therapeutic to Reduce the Recurrence of Clostridium difficile Infection (CDI) Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx163.968  0.278
2020 Diao L, O'Brien E, Ford C, Wortman J, Aunins J, Henn M. P075 Ser-287, An Investigational Microbiome Therapeutic, Induces Widespread Metabolomic And Host Transcriptional Changes Related To Clinical Remission In Patients With Active Mild-To-Moderate Ulcerative Colitis Gastroenterology. 158. DOI: 10.1053/J.Gastro.2019.11.290  0.263
2020 OBrien E, Diao L, Kieser K, Balasubramanian D, Nandakumar M, Pina A, Martinez A, Ford CB, Wortman JR, Auninš J, Henn MR. 35 SER-287, AN INVESTIGATIONAL MICROBIOME THERAPEUTIC, INDUCES IN VIVO AND IN VITRO METABOLOMIC CHANGES ASSOCIATED WITH CLINICAL REMISSION IN PATIENTS WITH ACTIVE MILD-TO-MODERATE ULCERATIVE COLITIS Gastroenterology. 158: S-13. DOI: 10.1016/S0016-5085(20)30715-0  0.259
2018 Henn M, Ford C, O’Brien E, Wortman J, Diao L, Desjardins C, Tomlinson A, Litcofsky K, Wilcox M, Buckley A, Bernardo P, McGovern B, Aunins JG, Cook DN, Trucksis M. 621. Treatment of Recurrent Clostridium difficile Infection with SER-109 Increases the Concentration of Secondary Bile Acids in a Dose-Dependent Manner Open Forum Infectious Diseases. 5. DOI: 10.1093/Ofid/Ofy210.628  0.253
2020 Henn MR, O'Brien EJ, Diao L, Feagan BG, Sandborn WJ, Huttenhower C, Wortman JR, McGovern BH, Wang-Weigand S, Lichter DI, Chafee M, Ford CB, Bernardo P, Zhao P, Simmons S, et al. A Phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis. Gastroenterology. PMID 32763240 DOI: 10.1053/J.Gastro.2020.07.048  0.242
2023 Straub TJ, Lombardo MJ, Bryant JA, Diao L, Lodise T, Freedberg DE, Wortman J, Litcofsky KD, Hasson BR, McGovern BH, Ford CB, Henn MR. Impact of a purified microbiome therapeutic on abundance of antimicrobial resistance genes in patients with recurrent Clostridioides difficile infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 37823484 DOI: 10.1093/cid/ciad636  0.238
2012 Li Y, Gierahn T, Thompson CM, Trzciński K, Ford CB, Croucher N, Gouveia P, Flechtner JB, Malley R, Lipsitch M. Distinct effects on diversifying selection by two mechanisms of immunity against Streptococcus pneumoniae. Plos Pathogens. 8: e1002989. PMID 23144610 DOI: 10.1371/Journal.Ppat.1002989  0.23
2020 Yu EW, Gao L, Stastka P, Cheney MC, Mahabamunuge J, Torres Soto M, Ford CB, Bryant JA, Henn MR, Hohmann EL. Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial. Plos Medicine. 17: e1003051. PMID 32150549 DOI: 10.1371/Journal.Pmed.1003051  0.223
2019 Yu EW, Gao L, Stastka P, Cheney MC, Mahabamunuge J, Soto MT, Ford C, Bryant JA, Henn MR, Hohmann EL. 622 – Double-Blind Randomized Placebo-Controlled Trial of Weekly Fecal Microbiota Transplantation (FMT) Capsules in Obese Adults: Evaluating Microbiota Engraftment and Improvements in Insulin Sensitivity Gastroenterology. 156: S-129-S-130. DOI: 10.1016/S0016-5085(19)37113-6  0.211
2022 Khanna S, Sims M, Louie TJ, Fischer M, LaPlante K, Allegretti J, Hasson BR, Fonte AT, McChalicher C, Ege DS, Bryant JA, Straub TJ, Ford CB, Henn MR, Wang EEL, et al. SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Infection (rCDI). Antibiotics (Basel, Switzerland). 11. PMID 36140013 DOI: 10.3390/antibiotics11091234  0.206
2020 Yu EW, Liu G, Stastka P, Cheney MC, Mahabamunuge J, Soto MT, Ford CB, Bryant JA, Henn MR, Hohmann EL. OR26-06 Fecal Microbiota Transplantation Trial for the Improvement of Metabolism (FMT-TRIM): A Randomized Double-Blind Placebo-Controlled Pilot Trial Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.995  0.202
2022 Feuerstadt P, Louie TJ, Lashner B, Wang EEL, Diao L, Bryant JA, Sims M, Kraft CS, Cohen SH, Berenson CS, Korman LY, Ford CB, Litcofsky KD, Lombardo MJ, Wortman JR, et al. SER-109, an Oral Microbiome Therapy for Recurrent Infection. The New England Journal of Medicine. 386: 220-229. PMID 35045228 DOI: 10.1056/NEJMoa2106516  0.161
2018 Farrer RA, Ford CB, Rhodes J, Delorey T, May RC, Fisher MC, Cloutman-Green E, Balloux F, Cuomo CA. Transcriptional Heterogeneity of VGII Compared with Non-VGII Lineages Underpins Key Pathogenicity Pathways. Msphere. 3. PMID 30355668 DOI: 10.1128/mSphere.00445-18  0.138
2007 Brown SB, Tucker CS, Ford C, Lee Y, Dunbar DR, Mullins JJ. Class III antiarrhythmic methanesulfonanilides inhibit leukocyte recruitment in zebrafish Journal of Leukocyte Biology. 82: 79-84. PMID 17431092 DOI: 10.1189/Jlb.0107030  0.133
2021 Normington C, Moura IB, Bryant JA, Ewin DJ, Clark EV, Kettle MJ, Harris HC, Spittal W, Davis G, Henn MR, Ford CB, Wilcox MH, Buckley AM. Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection. Npj Biofilms and Microbiomes. 7: 16. PMID 33547298 DOI: 10.1038/s41522-021-00184-w  0.129
2016 Robertson AL, Ogryzko NV, Henry KM, Loynes CA, Foulkes MJ, Meloni MM, Wang X, Ford C, Jackson M, Ingham PW, Wilson HL, Farrow SN, Solari R, Flower RJ, Jones S, et al. Identification of benzopyrone as a common structural feature in compounds with anti-inflammatory activity in a zebrafish phenotypic screen. Disease Models & Mechanisms. PMID 27079522 DOI: 10.1242/dmm.024935  0.123
2016 Drew DP, Andersen TB, Sweetman C, Møller BL, Ford C, Simonsen HT. Two key polymorphisms in a newly discovered allele of the Vitis vinifera TPS24 gene are responsible for the production of the rotundone precursor α-guaiene. Journal of Experimental Botany. 67: 799-808. PMID 26590310 DOI: 10.1093/jxb/erv491  0.095
2016 Akyüz N, Brandt A, Stein A, Schliffke S, Mährle T, Quidde J, Goekkurt E, Loges S, Haalck T, Ford C, Asemissen AM, Thiele B, Radloff J, Thenhausen T, Krohn-Grimberghe A, et al. T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker. International Journal of Cancer. PMID 27925177 DOI: 10.1002/ijc.30549  0.082
2014 Gao D, Madi M, Ding C, Fok M, Steele T, Ford C, Hunter L, Bing C. Interleukin-1β mediates macrophage-induced impairment of insulin signaling in human primary adipocytes. American Journal of Physiology. Endocrinology and Metabolism. 307: E289-304. PMID 24918199 DOI: 10.1152/ajpendo.00430.2013  0.066
2017 Howard IS, Ford C, Cangelosi A, Franklin DW. Active lead-in variability affects motor memory formation and slows motor learning. Scientific Reports. 7: 7806. PMID 28798355 DOI: 10.1038/S41598-017-05697-Z  0.061
2022 Ford C, Xie CX, Low A, Rajakariar K, Koshy AN, Sajeev JK, Roberts L, Pathik B, Teh AW. Comparison of 2 Smart Watch Algorithms for Detection of Atrial Fibrillation and the Benefit of Clinician Interpretation: SMART WARS Study. Jacc. Clinical Electrophysiology. 8: 782-791. PMID 35738855 DOI: 10.1016/j.jacep.2022.02.013  0.06
2013 Brandell B, Ford C. Diabetes professionals must seize the opportunity in mobile health. Journal of Diabetes Science and Technology. 7: 1616-20. PMID 24351188 DOI: 10.1177/193229681300700622  0.055
2019 Hu D, Sun X, Liao X, Zhang X, Zarabi S, Schimmer A, Hong Y, Ford C, Luo Y, Qi X. Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. Acta Neuropathologica. PMID 30877431 DOI: 10.1007/S00401-019-01993-2  0.049
2020 Gopalakrishnan V, Weiner B, Ford C, Sellman B, Hammond S, Freeman D, Dennis P, Soria J, Wortman J, Henn M. Intervention strategies for microbial therapeutics in cancer immunotherapy Immuno-Oncology Technology. 6: 9-17. DOI: 10.1016/j.iotech.2020.05.001  0.041
2008 Machado-Oliveira G, Lefièvre L, Ford C, Herrero MB, Barratt C, Connolly TJ, Nash K, Morales-Garcia A, Kirkman-Brown J, Publicover S. Mobilisation of Ca2+ stores and flagellar regulation in human sperm by S-nitrosylation: a role for NO synthesised in the female reproductive tract. Development (Cambridge, England). 135: 3677-86. PMID 18842814 DOI: 10.1242/dev.024521  0.04
2004 Martin JL, Ford CB, Dyer-Friedman J, Tang J, Huffman LC. Patterns of agreement between parent and child ratings of emotional and behavioral problems in an outpatient clinical setting: when children endorse more problems. Journal of Developmental and Behavioral Pediatrics : Jdbp. 25: 150-5. PMID 15194898 DOI: 10.1097/00004703-200406000-00002  0.034
2017 Ford C, Chang S, Vitolins MZ, Fenton JI, Howard BV, Rhee JJ, Stefanick M, Chen B, Snetselaar L, Urrutia R, Frazier-Wood AC. Evaluation of diet pattern and weight gain in postmenopausal women enrolled in the Women's Health Initiative Observational Study. The British Journal of Nutrition. 1-10. PMID 28509665 DOI: 10.1017/S0007114517000952  0.032
2008 Bedu-Addo K, Costello S, Harper C, Machado-Oliveira G, Lefievre L, Ford C, Barratt C, Publicover S. Mobilisation of stored calcium in the neck region of human sperm--a mechanism for regulation of flagellar activity. The International Journal of Developmental Biology. 52: 615-26. PMID 18649275 DOI: 10.1387/ijdb.072535kb  0.031
2018 Bugyei-Twum A, Ford C, Civitarese R, Seegobin J, Advani SL, Desjardins JF, Kabir G, Zhang Y, Mitchell M, Switzer J, Thai K, Shen V, Abadeh A, Singh KK, Billia F, et al. Sirtuin 1 Activation Attenuates Cardiac Fibrosis in a Rodent Pressure Overload Model by Modifying Smad2/3 Transactivation. Cardiovascular Research. PMID 29800064 DOI: 10.1093/cvr/cvy131  0.031
2011 Al-Bader M, Ford C, Al-Ayadhy B, Francis I. Analysis of estrogen receptor isoforms and variants in breast cancer cell lines. Experimental and Therapeutic Medicine. 2: 537-544. PMID 22977537 DOI: 10.3892/etm.2011.226  0.03
1985 Ford CB. Changes in ambulatory care in an urban hospital The Alumni Magazine. 85: 8-9. PMID 3931659  0.022
2013 Dall K, Ford C, Fisher R, Dunning J. Is there a survival advantage of incomplete resection of non-small-cell lung cancer that is found to be unresectable at thoracotomy? Interactive Cardiovascular and Thoracic Surgery. 16: 529-32. PMID 23315183 DOI: 10.1093/icvts/ivs428  0.017
1999 Turgeon PR, Pak-Kin M, Blake MA, Fee MF, Ford CB, Meaney PJ, Seigler R, Shen WW. S/390 G5/G6 binodal cache Ibm Journal of Research and Development. 43: 661-670.  0.017
2003 Jutte DP, Burgos A, Mendoza F, Ford CB, Huffman LC. Use of the Pediatric Symptom Checklist in a low-income, Mexican American population. Archives of Pediatrics & Adolescent Medicine. 157: 1169-76. PMID 14662568 DOI: 10.1001/archpedi.157.12.1169  0.016
2015 Laroche HH, Ford C, Hansen K, Cai X, Just DR, Hanks AS, Wansink B. Concession stand makeovers: a pilot study of offering healthy foods at high school concession stands. Journal of Public Health (Oxford, England). 37: 116-24. PMID 24623802 DOI: 10.1093/Pubmed/Fdu015  0.01
2014 Alfes CM, Conrad MA, Ford CB, Sullivan-Mann J, Weaver A. The journey of transitioning to a simulation nurse leader in Ohio Innovations in Nursing Education: Building the Future of Nursing. 2: 165-168.  0.01
2006 Qasim T, Ford C, Bush MB, Hu X, Lawn BR. Effect of off-axis concentrated loading on failure of curved brittle layer structures. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 76: 334-9. PMID 16130148 DOI: 10.1002/jbm.b.30373  0.01
Hide low-probability matches.